[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
September 22/29, 2010

Heart Valve Replacement

JAMA. 2010;304(12):1317. doi:10.1001/jama.2010.1335

Despite limited data on efficacy, percutaneous heart valve replacement (PHV) appears to be feasible option for patients who are not candidates for surgical aortic valve replacement, according to a review funded by the Agency for Health Care Research and Quality.

Remy R. Coeytaux, MD, PhD, of the Duke Clinical Research Institute and colleagues reviewed 76 case studies and series involving 2375 patients who underwent PHV via a catheter or transcatheter (Coeytaux RR et a. Ann Intern Med. 2010;153). They found a 94% success rate overall with 89% of patients surviving for 30 days. However, data on longer-term outcomes were limited. So far, the authors note, such studies have involved patients who would not be candidates for the surgical version of the procedure.

First Page Preview View Large
First page PDF preview
First page PDF preview